Irritable bowel syndrome in primary care: the patients' and doctors' views on symptoms, etiology and management
- PMID: 12813601
- DOI: 10.1155/2003/532138
Irritable bowel syndrome in primary care: the patients' and doctors' views on symptoms, etiology and management
Abstract
Background: To facilitate the development of clinical guidelines and to direct future irritable bowel syndrome (IBS) research, insight into the perceptions of patients and general practitioners (GPs) regarding IBS is required.
Objectives: To compare patients' and GPs' views on the symptomatology, etiology and treatment of IBS.
Methods: One hundred forty-two IBS patients and 100 GPs were requested to complete a structured questionnaire.
Results: The response rates of the patients and GPs were 80% and 47%, respectively. Abdominal pain and bloating were considered to be the most bothersome symptoms in IBS, by both patients and GPs. Although all patients were diagnosed by their GP as having IBS, and 62% met the Manning criteria, only 18% fulfilled the Rome II criteria for IBS. Patients consider food intolerance and GPs regard lack of fibre as the main etiologic dietary factor. Many IBS patients expect a diagnostic work-up, but GPs generally restrict this to elderly patients. GPs start IBS management with dietary advice (94%), counselling (77%) and drug therapy (55%). Patients expect reassurance (47%) and drug treatment (37%), but dietary interventions are less appreciated (9%).
Conclusions: Patients and GPs have different perceptions of the efficacy of diagnostic and dietary interventions in IBS. GPs should explore the patients expectations and incorporate these in their approach to IBS patients.
Similar articles
-
Medical and lay views of irritable bowel syndrome.Fam Pract. 2000 Apr;17(2):108-13. doi: 10.1093/fampra/17.2.108. Fam Pract. 2000. PMID: 10758070
-
Doctor-patient interaction for irritable bowel syndrome in primary care: a systematic perspective.Eur J Gastroenterol Hepatol. 2004 Nov;16(11):1161-6. doi: 10.1097/00042737-200411000-00013. Eur J Gastroenterol Hepatol. 2004. PMID: 15489576 Review.
-
Use of Rome criteria for the diagnosis of irritable bowel syndrome in primary care: a survey among European countries.Eur J Gastroenterol Hepatol. 2017 Jun;29(6):651-656. doi: 10.1097/MEG.0000000000000848. Eur J Gastroenterol Hepatol. 2017. PMID: 28125426
-
GPs' explanatory models for irritable bowel syndrome: a mismatch with patient models?Fam Pract. 2009 Feb;26(1):34-9. doi: 10.1093/fampra/cmn088. Epub 2008 Nov 14. Fam Pract. 2009. PMID: 19011171
-
Irritable bowel syndrome: overview of diagnosis and treatment.J La State Med Soc. 1999 Feb;151(2):76-81. J La State Med Soc. 1999. PMID: 11280840 Review.
Cited by
-
Wheat bran: its composition and benefits to health, a European perspective.Int J Food Sci Nutr. 2012 Dec;63(8):1001-13. doi: 10.3109/09637486.2012.687366. Epub 2012 Jun 20. Int J Food Sci Nutr. 2012. PMID: 22716911 Free PMC article. Review.
-
Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial.BMJ. 2009 Aug 27;339:b3154. doi: 10.1136/bmj.b3154. BMJ. 2009. PMID: 19713235 Free PMC article. Clinical Trial.
-
Epidemiologic Burden and Treatment of Chronic Symptomatic Functional Bowel Disorders in the United States: A Nationwide Analysis.Gastroenterology. 2021 Jan;160(1):88-98.e4. doi: 10.1053/j.gastro.2020.09.041. Epub 2020 Oct 1. Gastroenterology. 2021. PMID: 33010247 Free PMC article.
-
Tegaserod for the Treatment of Irritable Bowel Syndrome.Antiinflamm Antiallergy Agents Med Chem. 2020;19(4):342-369. doi: 10.2174/1871523018666190911121306. Antiinflamm Antiallergy Agents Med Chem. 2020. PMID: 31518227 Free PMC article. Review.
-
Irritable bowel syndrome and gastroesophageal reflux disease in primary care: is there a link?Dig Dis Sci. 2009 May;54(5):1079-86. doi: 10.1007/s10620-008-0462-0. Epub 2008 Aug 22. Dig Dis Sci. 2009. PMID: 18720002
Publication types
MeSH terms
LinkOut - more resources
Medical
Miscellaneous